2025 India Adult And Pediatric Vaccines Market Revenue Opportunities Report
Description
The 2025 India Adult And Pediatric Vaccines Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Adult and Pediatric Vaccines Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Adult and Pediatric Vaccines Market in India include the Serum Institute of India (SII), Bharat Biotech, Sanofi Pasteur, and GlaxoSmithKline (GSK). Serum Institute of India, headquartered in Pune, is the world’s largest vaccine manufacturer by volume, producing over 1.5 billion doses globally including Polio, DPT, Hib, BCG, and COVID-19 vaccines like Covishield. Bharat Biotech, based in Hyderabad, developed Covaxin—the first indigenous Indian COVID-19 vaccine—and actively collaborates with Indian health bodies for various vaccine innovations, including vaccines against Zika and Chikungunya viruses.
Multinational companies Sanofi Pasteur and GlaxoSmithKline also maintain a significant presence in India’s vaccine market. Sanofi Pasteur provides vaccines for polio, rabies, influenza, and is known for introducing advanced vaccines to the Indian pediatric and adult vaccine segments. GSK, headquartered in the UK, contributes vaccines for hepatitis, rotavirus, and influenza, leveraging collaborations with Indian health agencies to enhance vaccine access and immunization coverage. Together, these companies dominate the vaccine production and distribution landscape in India, supporting both government immunization programs and private sector healthcare needs.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Adult and Pediatric Vaccines Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Adult and Pediatric Vaccines Market in India include the Serum Institute of India (SII), Bharat Biotech, Sanofi Pasteur, and GlaxoSmithKline (GSK). Serum Institute of India, headquartered in Pune, is the world’s largest vaccine manufacturer by volume, producing over 1.5 billion doses globally including Polio, DPT, Hib, BCG, and COVID-19 vaccines like Covishield. Bharat Biotech, based in Hyderabad, developed Covaxin—the first indigenous Indian COVID-19 vaccine—and actively collaborates with Indian health bodies for various vaccine innovations, including vaccines against Zika and Chikungunya viruses.
Multinational companies Sanofi Pasteur and GlaxoSmithKline also maintain a significant presence in India’s vaccine market. Sanofi Pasteur provides vaccines for polio, rabies, influenza, and is known for introducing advanced vaccines to the Indian pediatric and adult vaccine segments. GSK, headquartered in the UK, contributes vaccines for hepatitis, rotavirus, and influenza, leveraging collaborations with Indian health agencies to enhance vaccine access and immunization coverage. Together, these companies dominate the vaccine production and distribution landscape in India, supporting both government immunization programs and private sector healthcare needs.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
